1. Home
  2. LSTA vs FGF Comparison

LSTA vs FGF Comparison

Compare LSTA & FGF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • FGF
  • Stock Information
  • Founded
  • LSTA 1980
  • FGF 2012
  • Country
  • LSTA United States
  • FGF United States
  • Employees
  • LSTA N/A
  • FGF N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • FGF Property-Casualty Insurers
  • Sector
  • LSTA Health Care
  • FGF Finance
  • Exchange
  • LSTA Nasdaq
  • FGF Nasdaq
  • Market Cap
  • LSTA 24.1M
  • FGF 20.9M
  • IPO Year
  • LSTA N/A
  • FGF N/A
  • Fundamental
  • Price
  • LSTA $2.91
  • FGF $17.83
  • Analyst Decision
  • LSTA Strong Buy
  • FGF
  • Analyst Count
  • LSTA 1
  • FGF 0
  • Target Price
  • LSTA $15.00
  • FGF N/A
  • AVG Volume (30 Days)
  • LSTA 21.4K
  • FGF 6.3K
  • Earning Date
  • LSTA 08-11-2025
  • FGF 08-13-2025
  • Dividend Yield
  • LSTA N/A
  • FGF N/A
  • EPS Growth
  • LSTA N/A
  • FGF N/A
  • EPS
  • LSTA N/A
  • FGF N/A
  • Revenue
  • LSTA $1,000,000.00
  • FGF $13,260,000.00
  • Revenue This Year
  • LSTA N/A
  • FGF N/A
  • Revenue Next Year
  • LSTA N/A
  • FGF N/A
  • P/E Ratio
  • LSTA N/A
  • FGF N/A
  • Revenue Growth
  • LSTA N/A
  • FGF N/A
  • 52 Week Low
  • LSTA $1.87
  • FGF $14.21
  • 52 Week High
  • LSTA $4.20
  • FGF $38.40
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 59.12
  • FGF 60.20
  • Support Level
  • LSTA $2.34
  • FGF $16.91
  • Resistance Level
  • LSTA $3.09
  • FGF $17.98
  • Average True Range (ATR)
  • LSTA 0.26
  • FGF 0.55
  • MACD
  • LSTA 0.02
  • FGF 0.04
  • Stochastic Oscillator
  • LSTA 76.00
  • FGF 64.65

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

About FGF FG Financial Group Inc. (NV)

Fundamental Global Inc through its subsidiaries operates as diversified insurance, reinsurance, and investment management holding company. The company's segments includes Insurance and Asset Management. It generates maximum revenue from the Insurance segment.

Share on Social Networks: